Pheniramine

Call us toll-free 1-866-978-4944 home about us contact us shipping q& a shop all drugs allergies anti-depressants anti-infectives anti-psychotics anti-smoking antibiotics asthma cancer cardio & blood cholesterol diabetes epilepsy gastrointestinal hair loss herpes hiv hormonal men's health muscle relaxers other pain relief parkinson's rheumatic skin care weight loss women's health allegra atarax benadryl clarinex claritin clemastine periactin phenergan pheniramine zyrtec anafranil celexa cymbalta desyrel effexor elavil, endep luvox moclobemide pamelor paxil prozac reboxetine remeron sinequan tofranil wellbutrin zoloft albenza amantadine aralen flagyl grisactin isoniazid myambutol pyrazinamide sporanox tinidazole vermox abilify clozaril compazine flupenthixol geodon haldol lamictal lithobid loxitane mellaril risperdal seroquel nicotine zyban achromycin augmentin bactrim biaxin ceclor cefepime ceftin chloromycetin cipro, ciloxan cleocin duricef floxin, ocuflox gatifloxacin ilosone keftab levaquin minomycin noroxin omnicef omnipen-n oxytetracycline rifater rulide suprax tegopen trimox vantin vibramycin zithromax advair aerolate, theo-24 brethine, bricanyl ketotifen metaproterenol proventil, ventolin serevent singulair arimidex casodex decadron eulexin femara levothroid, synthroid nolvadex provera, cycrin ultram vepesid zofran acenocoumarol aceon adalat, procardia altace atenolol amlodipine avapro caduet calan, isoptin capoten captopril hctz cardizem cardura catapres cilexetil, atacand clonidine, hctz combipres cordarone coreg coumadin cozaar dibenzyline diovan fosinopril hydrochlorothiazide hytrin hyzaar inderal ismo, imdur isordil, sorbitrate lanoxin lasix lercanidipine lopressor lotensin lozol micardis minipress moduretic normadate norpace norvasc plavix plendil prinivil, zestril prinzide rythmol tenoretic tenormin trental valsartan hctz vaseretic vasodilan vasotec zebeta crestor lipitor lopid mevacor pravachol tricor zocor accupril actos alpha-lipoic acid amaryl avandia diamicron mr glucophage glucotrol glucotrol xl glucovance lyrica micronase orinase prandin precose starlix depakote dilantin lamictal neurontin sodium valproate tegretol topamax trileptal valparin aciphex asacol bentyl cinnarizine colospa compazine cromolyn sodium cytotec imodium motilium nexium nexium fast pepcid ac pepcid complete prevacid prilosec propulsid protonix reglan stugil zantac zelnorm zofran propecia, proscar famvir rebetol valtrex zovirax combivir duovir-n epivir pyrazinamide retrovir sustiva videx viramune zerit ziagen aldactone calciferol danocrine decadron prednisone provera, cycrin synthroid avodart flomax hytrin levitra propecia, proscar viagra lioresal soma tizanidine ibuprofen zanaflex accupril alpha-lipoic acid amantadine aralen arcalion aricept ascorbic acid benadryl bentyl betahistine calciferol carbimazole compazine cyklokapron ddavp, stimate detrol dihydroergotoxine ditropan dramamine exelon florinef imitrex imuran isoniazid lasix melatonin myambutol nimotop orap persantine piracetam pletal quinine rifampin rifater rocaltrol strattera ticlid tiotropium urecholine urispas urso vermox zyloprim acetylsalicylic acid advil, medipren celebrex flunarizine imitrex ketorolac maxalt ponstel tylenol ultram benadryl ditropan eldepryl requip sinemet trivastal advil, medipren arava colchicine decadron feldene indocin sr mobic naprosyn zyloprim betamethasone differin nizoral oxsoralen prograf retin-a xenical advil, medipren allyloestrenol clomid, serophene diflucan evista folic acid fosamax isoflavone nexium parlodel ponstel prevacid prilosec progesterone provera, cycrin rocaltrol tibolone generic amoxyl, polymox, trimox, wymox generic name: amoxycillin ; qty.
Epilepsy although anticonvulsants are excreted into breast milk, most mothers who require the use of these drugs can safely breast-feed their infants and quetiapine. General Medication Administration Guidelines .45 Medication Safety Precautions .46. ASCENSIA MICROLET LANCING DEVICE . 18 aspirin caffeine butalbital . 11 atenolol, -w chlorthalidone . 14 atripla. 6 atropine sulfate . 25 ATROVENT . 27 AUTOJECT. 22 AUTONOMIC AND CNS MEDICATIONS10 AVANDAMET . 19 AVANDIA. 19 azathioprine . 10 azithromycin . 6 azithromycin susp. 6 AZMACORT . 27 AZOPT. 25 B bacitracin, -polymyxin b . 6 bacitracin polymyxin b ophth . 25 baclofen . 22 BACTROBAN CREAM . 6 BARACLUDE. 6 belladonna alkaloids-opium . 21 benazepril hcl, -w hctz . 14 BENICAR, -HCT . 14 benztropine mesylate . 11 betamethasone. 19 betamethasone dipropionate, -valerate . 16 betaxolol . 25 bethanecol . 27 BETOPTICS . 25 BICITRA . 27 bisacodyl. 21 bismuth subsalicylate . 21 bisoprolol fumarate, -w hctz. 14 brimonidine tartrate. 25 bromocriptine mesylate. 11 brompheniramine maleate . 5 brompheniramine-pseudoephedrine. 5 . 5 bumetanide. 14 bupropion. 11 bupropion sr . 11 buspirone hcl. 11 butoconazole. 6 C caffeine citrate oral solution. 11 calciferol . 24 calcitriol . 24 calcium carbonate . 24 calcium citrate . 24 CANASA . 21 capsaicin . 16 captopril, -w hctz . 14 CARBACHOL. 25 carbamazepine. 11 carbidopa levodopa . 11 carbinoxamine-pseudoephedrine . 5 carbinoxamine-pseudoephedrine-DM . 5 CARDIOVASCULAR MEDICATIONS . 14 carisoprodol. 23 carteolol hcl . 25 CASODEX. 10 CATAPRES TTS . 14 cefaclor. 6 cefadroxil. 6 cefadroxil hydrate . 6 CEFDINIR . 6 CEFPODOXIME. 6 CEFTIN SUSPENSION. 6 cefuroxime, -axetil . 6 CELLCEPT. 10 CELONTIN . 11 cephalexin . 6 cephradine . 6 chloral hydrate. 11 chloramphenicol . 25 chlordiazepoxide . 11 chloroquine phosphate . 6 chlorothiazide . 14 chlorpheniramine maleate . 5 chlorpheniramine-phenylephrine . 5 chlorpheniramine-pseudoephedrine . 5 chlorphen-phenyleph-hydrocodone . 5 and seroquel. A. Sestito 1 , G.A. Lanza 1 , D. Cianflone 2 , A.G. Rebuzzi 1 , G. Angeloni 1 , H. Raiswell 1 , F. Crea 1 , A. Maseri 2 on behalf of SPAI Stratificazione Prognostica dell'Angina Instabile ; Study Group. 1 Policlinico A. Gemelli, Istituto di Cardiologia, Rome, Italy; 2 Universit Vita e Salute, Istituto di Cardiologia, Milano, Italy Background: Several previous studies have shown that transient myocardial ischaemia TMI ; detected on 24-hour ECG Holter monitoring HM ; in patients with unstable angina UA ; is associated with a worse outcome. However, there is poor knowledge about whether TMI adds independent predictive value to C-reactive protein CRP ; and to troponins in this clinical context. Method: We analysed ECG Holter recordings of 583 patients with UA age 6510 years, 356 men ; , enrolledin the multicenter prospective Italian study "Stratificazione Prognostica dell'Angina Instabile" SPAI ; , who underwent 24-hour HM within 24 hours of hospital admission. Serum CRP and plasma troponin I TnI ; were measured at admission. As an inclusion criterion, all patients had a left ventricular ejection fraction 40%. During. During 6-month follow-up, there were 32 total deaths 6.5% ; , 29 of which 5.9% ; of cardiac origin. Furthermore, 12 non fatal acute myocardial infarctions 2.7% ; occurred, thus resulting in 41 7.5% ; total major cardiac events MCE cardiac death or acute myocardial infarction ; . One or more episodes of TMI on HM were detected in 139 patients 25.6%; median 4; range 1-20 ; . Patients were dichotomised with regard to CRP into those with serum levels 3 or 3 mg L, and with regard to TnI into those with plasma levels 0.4 or 0.4 ng mL. At 6-month follow-up, death occurred in 15 patients with 11.8% ; and in 17 without 4.7% ; TMI p 0.007 ; . MCE, on the other hand, occurred in 21 patients with 17.1% ; and in 31 without 8.8% ; TMI p 0.012 ; . TMI RR 2.98, 95%CL 1.18.2, p 0.034 ; , but not CRP and TnI, was significantly predictive of death at multivariate Cox survival analysis, including several potential clinical prognostic variables age, gender, cardiac risk factors, type of UA, previous myocardial infarction ; . On the other hand, TMI RR 2.07, 95%CL 1.0-4.2, p 0.047 ; , TnI 0.4 ng mL RR 2.02, 95%CL 1.0-3.9, p 0.030 ; and CRP 3 mg L RR 2.57.
The cold-submerged frogs appears to be equally partitioned between the extracellular and intracellular fluid compartments of the whole animal: there is no significant increase in the ratio of extracellular fluid to total body mass %ECV; Table 2 ; . The total water content Vm ; of the ventricular muscle in both sets of frogs increases significantly, after 4 months, as a result of small increases in both Vi and Vem. However, while the gastrocnemius muscles from the normoxic submerged frogs also increased their Vm, this was combined with a significant increase in Vem; i.e. the extracellular compartment became oedematous. The converse was true for the skeletal muscle from the hypoxic-submerged frogs: there was no significant change in Vm, while the volume of the intracellular fluid compartment Vi decreased Table 2 ; . Discussion The ability of the frog R. temporaria to down-regulate its metabolic rate to a new steady-state value is the key to its survival during prolonged periods of cold-submergence and or hypoxia. The reduction in whole-animal metabolic rate is thought to be brought about by hypoperfusion of an oxyconforming skeletal muscle mass that makes up 3540 % of the total mass of the animal Donohoe and Boutilier, 1998, 1999; Donohoe et al., 1998 ; . One of the cellular mechanisms proposed to lead to a reduction in the metabolic rate of muscle tissue is ion channel suppression Hochachka, 1986 ; . This may occur as a result of a generalised decrease in cell membrane permeability to ions or through a decline in the electrochemical gradient for maintaining ionic homeostasis. Both these processes would reduce the demand for Na + K -ATPase activity and could, therefore, be construed as energy-sparing responses. In this light, the hibernation-induced change in intracellular [K + ] and decreases in Na + and K + flux rates of skeletal muscle suggest energy-sparing responses that bring about the hypometabolic response to cold-submergence. Plasma [Na + ] falls to a new set point over the first week of cold-submergence that is one-third below the levels seen in airbreathing control animals at 3 C Fig. 4B ; . This decrease sets up the possibility of energetic savings both at the cutaneous interface with the environment and at the sarcolemmal level for the cold-submerged frog. The amphibian skin serves as a major osmoregulatory organ which, along with the kidney, is responsible for maintaining ionic and osmotic homeostasis. However, the skin of the cold-submerged frog has another, potentially conflicting, role as the sole organ of gas exchange, in that it responds to reduced oxygen availability by increasing its functional surface area through capillary recruitment i.e. hyperperfusion; Boutilier et al., 1986b; Pinder, 1987 ; . While an increased functional surface area facilitates gas exchange under O2-limiting conditions Boutilier et al., 1992 ; , it has the disadvantage of increasing the passive loss of ions from the animal to the environment. Thus, to maintain water and electrolyte balance at minimum cost, an `osmoregulatory compromise' must be reached between increasing the surface area required for gas exchange and minimising the surface area and quinine.
The symbols and codes are explained at the bottom of each timetable page. Mae'r symbolau a'r codau wedi eu hegluro ar waelod pob tudalen amserlen. A. Professional Affiliations: 1. Current Professional and Scientific Organizations and Societies * -require election or examination for membership ; : American Academy of Dermatology American Society of Dermatopathology Association of Professors of Dermatology National Association of Military Dermatology San Antonio Dermatologic Society Society of Investigative Dermatology Space Dermatology Foundation 2. Past and Current Positions and or Offices Held in Professional Organizations: Texas Dermatologic Society - Secretary Treasurer, 1992-1995 Texas Dermatologic Society - President 1996-97 Program Director of the South Central Southeastern Dermatological Society, 1996-97 President of the South Central Southeastern Dermatological Society, 1997-98 3. Other Professional Activities National and State Consultantships, Review Panels and Committees, Editorial Boards, Continuing Education Lectures Presented, etc. ; : Member of Medical Advisory Board of San Antonio Lupus Foundation Member of Medical Consultants Committee, 1983 Member of Records Review Committee for MCH, 1982 4. Community Activities American Cancer Society, American Lung Association, etc. ; : Member of St. Louis Catholic Church Member of Texas Farm Bureau Association Agrifood Master Program for Bexar County B. Patient Service Attending rounds, clinic responsibilities; minimum of two years ; : 1. Inpatient: Rounds on dermatology inpatients Consultation for dermatologic problems and rebetol. Zocor Tab 40mg Zocor Tab 80mg Acrivastine Cap 8mg Semprex Cap 8mg Benadryl Allergy Relief Cap 8mg Mizolastine Tab 10mg M R Mizollen Tab 10mg Desloratadine Tab 5mg Desloratadine Oral Soln 2.5mg 5ml Neoclarityn Tab 5mg Neoclarityn Syr 500mcg ml Levocetirizine Tab 5mg Xyzal Tab 5mg Azatadine Mal Elix 500mcg 5ml Loratadine Tab 10mg Loratadine Syr 5mg 5ml Clarityn Tab 10mg Clarityn Syr 5mg 5ml Fexofenadine HCl Tab 120mg Fexofenadine HCl Tab 180mg Telfast 120 Tab 120mg Telfast 180 Tab 180mg Brompheniramine Mal Elix 2mg 5ml Dimotane Elix 2mg 5ml Chlorphenamine Mal Inj 10mg ml 1ml Amp Chlorphenamine Mal Oral Soln 2mg 5ml Chlorphenamine Mal Tab 4mg Chlorphenamine Mal OralSoln 2mg 5mlS F Piriton Tab 4mg Piriton Syr 2mg 5ml Clemastine Fumar Tab 1mg Tavegil Tab 1mg Cetirizine HCl Tab 10mg Cetirizine HCl Oral Soln 1mg 1ml S F Zirtek Tab 10mg Zirtek Drinkable Soln 1mg 1ml S F. Abstract Chlorpheniramine, a histamine H1 receptor antagonist, was assayed for in vitro antimalarial activity against multidrug-resistant Plasmodium falciparum K1 strain and chloroquine-resistant P. falciparum T9 94 clone, by measuring the 3H-hypoxanthine incorporation. Chlorphenirame inhibited P. falciparum K1 and T9 94 growth with IC50 values of 136.0 40.2M and 102.0 22.6M respectively. A combination of antimalarial drug and chlorpheniramine was tested against resistant P. falciparum in vitro. Isobologram analysis showed that chlorpheniramine exerts marked synergistic action on chloroquine against P. falciparum K1 and T9 94. Chlorpheniramine also potentiated antimalarial action of mefloquine, quinine or pyronaridine against both of the resistant strains of P. falciparum. However, chlorpheniramine antagonism with artesunate was obtained in both P. falciparum K1 and T9 94. The results in this study indicate that antihistaminic drugs may be promising candidates for potentiating antimalarial drug action against drug resistant malarial parasites. 2006 Elsevier Ireland Ltd. All rights reserved and ribavirin and pheniramine. The expert consensus panel members considered the time of onset for toxicity to develop after valproic acid ingestion to assist in making decisions about out-of-hospital management. All articles with toxicity information were searched for estimates of a time of onset. Unfortunately, the majority of articles reported times of hospital presentation, rather than times of symptom development. In such cases, it was only possible to establish an upper limit for the time to effect onset. Only a few reports reported a precise time of effect onset. Care should be taken to distinguish time to onset of initial effects from time to onset of serious or major effects, the time to onset of peak effects, or the time to onset of subsequent deterioration or complications. There were six level 4 articles that specifically mentioned delayed onsets of clinical effects after valproic acid ingestion 9, 50, 66, ; . On closer review, many of these patients had early symptoms followed by delayed deteriorations in their conditions. A few reports appeared to represent genuine cases of delayed onset of toxicity. One adult with a suicide attempt presented awake with a therapeutic serum concentration of valproic acid of 70 mg L 3 hours after ingesting an unknown amount of the drug along with paroxetine, clonazepam, and ethanol. Nine to 11 hours after ingestion, he developed lethargy and poor arousability, followed by hypotension and hyperammonemia. His peak valproic acid serum concentration at 12 hours after the reported time of ingestion was 574 mg L. The specific type of valproic acid formulation was not mentioned in this report 74 ; . In another case report, a 32-year-old woman with a history of multiple suicide attempts ingested 30 g of divalproex sodium along with 400 mg of chlorpheniramine and was noted to have elevated serum bilirubin and AST concentrations on admission, 3 hours after ingestion. She did not develop clinical symptoms of toxicity until 48 hours after ingestion, when she became drowsy and went on to develop severe toxicity. Her valproic acid serum concentrations were 105 mg L at 4 hours after the reported time of ingestion, 825 mg L at 14 hours and a peak of 1380 mg L at 17 hours 50 ; . In third case, a 24-year-old woman ingested divalproex sodium along with dimenhydrinate. At 8 hours after ingestion, she was lethargic and she became comatose at 13 hours after ingestion 72 ; . In both of the latter two cases, the patients had ingested either delayed-release or extended-release formulations and also ingested drugs known to slow gastrointestinal motility. This could be an explanation for the delayed onset of effect. In the only pediatric case report with delayed onset of effect, a 26-month-old boy who ingested 4.5 g of divalproex sodium 288 mg kg ; was asymptomatic on admission 1 hours after ingestion and was noted to abruptly become obtunded and limp 4 hours after ingestion 9 ; . In many cases, it was difficult to assess the rapidity of effect onset or deterioration because the patients were found or presented to a hospital with significant effects already present or the rapidity of their deterioration was not reported by the authors. In a number of cases, the onset of toxicity appeared to be progressive over the course of minutes to hours 43, 57, 58, ; . Occasionally, the onset of symptoms was noted to be abrupt 9, 51, 77 ; . Treatment Measures Gastrointestinal Decontamination There were a number of different gastrointestinal decontamination measures reported in case reports including activated charcoal, ipecac syrup, and gastric lavage. There were no controlled trials investigating the efficacy of these procedures in valproic acid overdose patients. Several uncontrolled case reports and series mentioned the use of these decontamination measures in individual patients, but it was impossible to determine the efficacy of any of these measures from these reports given the lack of controls, the concurrent use of other therapies, and the fact that decontamination procedures do not generally produce immediate clinical improvement. A level 1b prospective trial investigated the efficacy of activated charcoal on valproic acid absorption in volunteers. In this study, both peak serum valproate concentration and AUC were significantly reduced mean 65% reduction in absorption, P 0.01 ; by 50 g activated charcoal administered 5 minutes after ingestion of 300 mg valproate sodium 78 ; . Another level 1b controlled trial looked at the efficacy of multiple-dose activated charcoal in enhancing valproate elimination after therapeutic doses of valproate sodium syrup and found the regimen tested did not significantly reduce the serum half-life of valproate; however, the first dose of activated charcoal was not administered until 4 hours after the sodium valproate 42 ; . In another paper, a 26-month-old boy with an ingestion of 4.5 g of extended-release valproic acid was given a continuous gastric infusion of activated charcoal at a rate of 0.25 g kg hour. The authors reported an elimination half-life of 4.8 hours versus an expected half-life of 1016 hours 9 ; . There were no prospective studies looking at the efficacy of ipecac syrup or gastric lavage in valproic acid exposures. Naloxone There were several level 4 case reports of patients improving significantly after naloxone administration with reversal of coma, respiratory depression, and pinpoint pupils 79, 40, 65, ; . There were a number of other. The first study to demonstrate a sex specific of zebra mussel spawning at a time when both sexes are capable of spawning. All experiments included a positive control group in which animals were exposed to 5-HT, demonstrating that both sexes were capable of spawning, yet metergoline selectively induced males. The observation that metergoline induced spawning at low concentrations, but inhibited spawning at high concentrations may be attributed to mixed agonist antagonist properties of this drug. Previously, male-only responses have been obtained with cold-stored, late season, or early season zebra mussels20, 29, a result attributed to lack of readiness of females to respond. In the present study, females were competent to respond. These results suggest that the 5-HT receptors in females are either less accessible to metergoline the need for ethanol to solubilize metergoline indicates it is more hydrophobic than 5-HT ; or that the effective 5-HT receptors for inducing spawning differ between males and females. Some of these questions may be resolved by in vitro investigations of the spawning mechanism and by investigating the structure and binding properties of 5-HT receptors in zebra mussels. The presence of novel 5-HT receptors mediating germinal vesicle breakdown GVBD ; in bivalve oocytes has been suggested30-32. Previous studies in our laboratory33 have demonstrated that GVBD occurs in zebra mussel ovaries prior to spawning in response to 5-HT. Radioligand binding assays and pharmacological characterizations with surf clams Spisula ; 31, 32 demonstrated novel 5-HT binding sites 5-HT, ; on oocyte plasma membranes and vitelline envelopes. Thus, GVBD and spawning in Dreissena and GVBD in Spisula may be mediated by a new class of 5-HT receptors, possibly similar to 5-HTlym and requip.
Chlorpheniramine M. and Phenylpropanolamine. CEENU, 8 cefaclor, er, 3 cefadroxil, monohydrate, 3 cefazolin [INJ], 3 cefazolin sodium [INJ], 3 cefotaxime, sodium [INJ], 3 cefoxitin [INJ], 3 cefpodoxime proxetil, 3 cefprozil, 3 ceftazidime inj 1, 000 gm, 2, 000 gm, 6, 000 gm [INJ], 3 CEFTIN susp, 3 ceftriaxone, sodium [INJ], 3 cefuroxime sodium [INJ], 3 cefuroxime, axetil, 3 CELEBREX, 33 CELLCEPT, 8 CELONTIN, 16 cena-k, 37 cephalexin, 3 CEREBYX [INJ], 14 CEREZYME [INJ], 26 cerovel, 23 cesia, 38 CHANTIX, 16 CHEMET, 24 chloral hydrate, 16 chloramphenicol sod succinate [INJ], 3 chlorhexidine gluconate dental products, 25 CHLORHEXIDINE GLUCONATE soln, top, 7 chloroprocaine hcl [INJ], 1 chloroquine phosphate, 6 chlorothiazide, 21 chlorpheniramine maleate, 43 chlorpromazine hcl, 12 chlorpropamide [CARE], 26 chlortan, 43 chlorthalidone, 21 chlorzoxazone [CARE], 32 cholestyramine, light, 19 choline mag trisalicylate, 34 ciclopirox, olamine, 5 cilostazol, 34 cimetidine, hcl, 28 CIPRO I.V. inj 200 mg ml, 400 mg ml [INJ], 6 CIPRODEX, 24 ciprofloxacin [INJ], 6 ciprofloxacin er, hcl, 6 ciprofloxacin hcl, 24, 41 cisplatin [INJ], 8 citalopram, hbr, 16 55. Kronofed-A-Jr. generic only ; pseudoephedrine chlorpheniramine. Block NF-kB induction. There are no untoward or neurobehavioural effects, such as sedation or motor impairment. They do not induce QTc prolongation or other adverse electrocardiographic effects cardiac arrythmias torsade de pointes ; . There is no concern about possible cardiac arrythmias as there are no drug interactions with co-administration with erythromycin or ketoconazole.They do not interact with cytochrome P450 inhibitors such as cimetidine, cyclosporine and nifedipine. They have rapid absorption and its extent is not altered by food. They have a high affinity, persistent binding and specificity for H1 receptors. There is no problem of tachyphylaxis which is seen with the sedative antihistamines. Safe and well tolerated, they represent a major advance in the management of urticaria. Levocetirazine is the active enantiomer of the racemate cetirizine, fexofenadine the active metabolite of terfinadine and desloratadine an active metabolite of loratadine. The majority of patients with urticaria can be controlled on the above-mentioned new-generation antihistamines. In cases of severe refractory chronic idiopathic urticaria the new-generation antihistamine dosage can be doubled. The second-generation antihistamines including loratadine, mizolastine and ebastine are also well tolerated. The addition of a sedating antihistamine, such as hydroxyzine or chlorpheniramine, at night can be helpful when sleep is disturbed by itching that occurs predominantly at night. Use of a sedating antihistamine as monotherapy for chronic urticaria is not recommended because of impairment of psychomotor performance such as driving. The old-generation sedative antihistamines also have anticholinergic side-effects. Chlorpheniramine is the only antihistamine that is safe in pregnancy, but should not be used in the first trimester. The addition of H2 antagonists such as ranitidine to conventional H1 antihistamines may be helpful in some patients with chronic urticaria.